Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...
Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...
Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...
The proceeds of the Transaction are expected to result in a total cumulative gross amount of at least EUR 7 million in ...
Pollen Allergy Market. The global pollen allergy market, valued at approximately USD 5850.8 million in 2023, is on a promising growth trajectory, driven by advancements in healthc ...
On September 27, 2024, the U.S. Court of Appeals for the Ninth Circuit reversed the district court’s decision in U.S. v. California Stem ...